Journal: bioRxiv
Article Title: Tumor suppressor p53 controls thymic NKT17 development
doi: 10.1101/2024.08.21.608967
Figure Lengend Snippet: (A) Conventional T cells develop normally in the absence of p53. Upper panel, CD4 and CD8 profile of total thymocytes. Lower panel, CD4 and CD8 profile of TCRβ high matured thymocytes. (B) Representative gating strategy for thymic NKT1 , NKT2 and NKT17 subsets. (C) p53 protein expression levels were analyzed by flow cytometry at steady state and after irradiation. For irradiation condition, cells were irradiated (1,000 rad) and incubated for 4 hours at 37°C. Data is pooled result of two independent experiments. (D) γH2AX expression in thymic iNKT subset was analyzed by flow cytometry. Data are mean ± SEM. Statistical differences between groups were analyzed with One-way ANOVA followed by multiple comparison. * * p < 0.005, * * * p < 0.0001.
Article Snippet: Anti-CD4 (RM4-5)-BV510 (Need clone name or described it in Star Protocol), anti-B220 (RA3-6B2)-AF700, anti-CD44 (IM7)-FITC, anti-TCRβ (H57-597)-PE/Cy7, anti-RORγt (Q31-378)-BV786, anti-T-bet (O4-46)-BV421, anti-PLZF (R17-809)-AF647, anti-CCR7 (4B12)-BV786, anti-IL-17A (TC11-18H10)-FITC, anti-IFNγ (XMG1.2)-FITC, anti-IL-4 (11B11)-BV421 were purchased from BD Biosciences.
Techniques: Expressing, Flow Cytometry, Irradiation, Incubation, Comparison